| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SOD2 overlapping transcript 1 | 0.722 | 0.500 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
long intergenic non-protein coding RNA 462 | 0.861 | 0.192 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
FGF13 antisense RNA 1 | 0.931 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
ubiquitin conjugating enzyme E2 C pseudogene 3 | 0.931 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
TFAP2A antisense RNA 1 | 0.890 | 0.115 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
RAB6C antisense RNA 1 | 0.839 | 0.154 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 887 | 0.821 | 0.192 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
FAM83A antisense RNA 1 | 0.821 | 0.115 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
DNMT1-associated colon cancer repressed lncRNA 1 | 0.931 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
long intergenic non-protein coding RNA 271 | 0.769 | 0.192 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
zinc finger protein 717 | 1.000 | 0.077 | 1.9E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ACTA2 antisense RNA 1 | 0.769 | 0.231 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
CALML3 antisense RNA 1 | 0.821 | 0.115 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1512 | 0.890 | 0.154 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
Fc fragment of IgG receptor Ic, pseudogene | 0.769 | 0.462 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
family with sequence similarity 99 member B | 1.000 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
FOXO induced long non-coding RNA 1 | 0.861 | 0.115 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
hypophosphatemic bone disease | 0.780 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
Prostate cancer, hereditary, 7 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | |||||||||||
|
long intergenic non-protein coding RNA 426 | 0.861 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
tRNA-Val (anticodon CAC) 2-1 | 1.000 | 0.038 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
RAMP2 antisense RNA 1 | 1.000 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
phosphatidylinositol glycan anchor biosynthesis class K | 0.839 | 0.154 | 1.4E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
long intergenic non-protein coding RNA 899 | 0.792 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
C-X9-C motif containing 4 | 0.931 | 0.192 | 0.16 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 |